| A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer (NCT03117920) | Minneamrita Therapeutics LLC | 2017-04-10 |
| 68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer (NCT03113617) | Andrei Iagaru | 2017-04-10 |
| Inhibition of Anaphylaxis by Ibrutinib (NCT03149315) | Ann & Robert H Lurie Children's Hospital of Chicago | 2017-04-10 |
| Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension (NCT02911844) | University of Pennsylvania | 2017-04-10 |
| Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma (NCT03126708) | Peking University | 2017-04-10 |
| Enhancing Recovery in Early Schizophrenia (NCT02926859) | Central Institute of Mental Health, Mannheim | 2017-04-08 |
| Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) (NCT06365424) | Xijing Hospital of Digestive Diseases | 2017-04-08 |
| Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer (NCT03137771) | NRG Oncology | 2017-04-07 |
| PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies (NCT03044743) | Yang Yang | 2017-04-07 |
| Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST) (NCT03109301) | National Cancer Institute (NCI) | 2017-04-07 |
| Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy (NCT03193047) | Esperion Therapeutics, Inc. | 2017-04-07 |
| Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer (NCT03091491) | National Cancer Centre, Singapore | 2017-04-07 |
| the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer (NCT03196869) | Guiyang Medical University | 2017-04-07 |
| Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1) (NCT02808871) | Brigham and Women's Hospital | 2017-04-07 |
| Study of ONO-8577 in Patients With Overactive Bladder (NCT03106623) | Ono Pharmaceutical Co., Ltd. | 2017-04-07 |
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors (NCT03108131) | M.D. Anderson Cancer Center | 2017-04-07 |
| ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) (NCT03113968) | Bo Hu | 2017-04-07 |
| Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease (NCT03077542) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-04-06 |
| Treatment of NAFLD With Two Different Diets (NCT03118310) | Karolinska University Hospital | 2017-04-06 |
| Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma (NCT03113266) | Shanghai Junshi Bioscience Co., Ltd. | 2017-04-06 |
| Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers (NCT02830724) | National Cancer Institute (NCI) | 2017-04-06 |
| Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL (NCT03097107) | Zydus Therapeutics Inc. | 2017-04-06 |
| Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT (NCT02876679) | Assistance Publique - Hôpitaux de Paris | 2017-04-06 |
| Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia (NCT02931565) | Cyclerion Therapeutics | 2017-04-06 |
| Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (NCT02484430) | National Cancer Institute (NCI) | 2017-04-06 |
| Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis (NCT03061721) | Zydus Therapeutics Inc. | 2017-04-06 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease (NCT03077412) | Gilead Sciences | 2017-04-06 |
| Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women (NCT02722421) | University of Nebraska | 2017-04-06 |
| Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL) (NCT02983617) | Gilead Sciences | 2017-04-06 |
| Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJA (NCT03116555) | China Medical University, China | 2017-04-05 |
| Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2 (NCT04345900) | BeyondSpring Pharmaceuticals Inc. | 2017-04-05 |
| Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery (NCT03007030) | M.D. Anderson Cancer Center | 2017-04-05 |
| Brain Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation (NCT03102359) | Huazhong University of Science and Technology | 2017-04-05 |
| Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells (NCT03107416) | Memorial Sloan Kettering Cancer Center | 2017-04-05 |
| Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial (NCT03003390) | Yale University | 2017-04-05 |
| Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia (NCT02961218) | Novartis Pharmaceuticals | 2017-04-05 |
| Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects (NCT03224338) | Blueclinical, Ltd. | 2017-04-05 |
| Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid (NCT03124108) | Genfit | 2017-04-05 |
| Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 (NCT03050814) | National Cancer Institute (NCI) | 2017-04-05 |
| CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma (NCT03118180) | Zhejiang University | 2017-04-05 |
| Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Dexmedetomidine. (NCT03120247) | Assiut University | 2017-04-05 |
| Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery (NCT03070886) | NRG Oncology | 2017-04-05 |
| Diffuse Optical Monitoring With Inhaled Nitric Oxide (NCT03023449) | Steven Messe | 2017-04-04 |
| iHIVARNA Clinical Trial in HIV Infected Individuals (NCT02888756) | Rob Gruters | 2017-04-04 |
| Multicentre International STudy for the Prevention With Ialuril® of Radio-induced Cystitis (MISTIC) (NCT03493997) | Study Group for Urogenital Diseases, Italy | 2017-04-04 |
| A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients (NCT02879617) | Academic Thoracic Oncology Medical Investigators Consortium | 2017-04-04 |
| Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis (NCT03308045) | Eyevensys | 2017-04-04 |
| Efficacy and Safety Study of Gabapentin as add-on to Morphine in Paediatric Patients Affected by Chronic Pain (NCT03275012) | Pharmaceutical Research Management srl | 2017-04-04 |
| Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia (NCT02782949) | National Cancer Institute (NCI) | 2017-04-04 |
| ProF-001_Phase IIa (NCT03115073) | ProFem GmbH | 2017-04-04 |
| IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery (NCT03029611) | University of Washington | 2017-04-03 |
| Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma (NCT03076281) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2017-04-03 |
| Safety and Efficacy of Liraglutide in Parkinson's Disease (NCT02953665) | Cedars-Sinai Medical Center | 2017-04-03 |
| UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone (NCT03139747) | Thomas Jefferson University | 2017-04-03 |
| Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children (NCT02948829) | Takeda | 2017-04-03 |
| Comparison of Antibacterial Efficacy of Three Final Irrigants (NCT03853200) | Dow University of Health Sciences | 2017-04-03 |
| PREMIX vs PREMED Intranasal Lidocaine and Midazolam (NCT03054844) | Columbia University | 2017-04-03 |
| Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma (NCT03057795) | City of Hope Medical Center | 2017-04-03 |
| Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma (NCT03031483) | International Extranodal Lymphoma Study Group (IELSG) | 2017-04-03 |
| Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease (NCT03062176) | Virginia Commonwealth University | 2017-04-03 |
| Oral Nitrite for Older Heart Failure With Preserved Ejection Fraction (NCT02918552) | Gladwin, Mark, MD | 2017-04-03 |
| Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab (NCT03093155) | Yale University | 2017-04-03 |
| Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer (NCT02775695) | Medical College of Wisconsin | 2017-04-03 |
| Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome (NCT03162094) | Avizorex Pharma, S.L. | 2017-04-03 |
| Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury (NCT02962102) | David Leaf | 2017-04-03 |
| Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia (NCT02981745) | Centaurus Biopharma Co., Ltd. | 2017-04-01 |
| Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate (NCT02944201) | Montefiore Medical Center | 2017-04-01 |
| Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations (NCT02747797) | Teresa Helsten, MD | 2017-04-01 |
| Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta? (NCT03208582) | Sheffield Children's NHS Foundation Trust | 2017-04-01 |
| TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) (NCT03093701) | Taiwan Liposome Company | 2017-04-01 |
| Phase II Proof of Concept Study in Uncomplicated UTI (NCT03129295) | Mission Pharmacal | 2017-04-01 |
| Single Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD) (NCT03086395) | Case Comprehensive Cancer Center | 2017-04-01 |
| Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD (NCT03012646) | United Therapeutics | 2017-04-01 |
| Fecal Microbiota Transplantation for the Treatment of Obesity (NCT02741518) | Brigham and Women's Hospital | 2017-04-01 |
| β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC (NCT03123484) | China Medical University, China | 2017-04-01 |
| Green Tea With Aloe Vera Mouthwash and Chlorohexidine Mouthwash (NCT03115892) | Cairo University | 2017-04-01 |
| Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20 (NCT03097770) | Chinese PLA General Hospital | 2017-04-01 |
| Effect of Post-operative Ibuprofen After Surgery for Chronic Rhinosinusitis (NCT03055507) | University of Washington | 2017-04-01 |
| Dose Assessment of Melatonin in Sepsis Trial (NCT02319265) | University of Aberdeen | 2017-04-01 |
| A Trial of Topical Aloe Vera Gel in Emergency Department Patients Presenting With Simple Traumatic Wounds (NCT02819817) | NHS Lothian | 2017-04-01 |
| Patient Controlled Remifentanil Analgesia for Normal Labour (NCT04541719) | Mansoura University | 2017-04-01 |
| Effect of Topical and Systemic Tranexemic Acid on Bleeding During Ear Exploration Surgery (NCT03112135) | Assiut University | 2017-04-01 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis (NCT03275025) | Yungjin Pharm. Co., Ltd. | 2017-04-01 |
| 2015-09: a Phase II Randomized, Open-label Study of Anti-signaling Lymphocytic Activation Molecule Monoclonal Antibody During Maintenance Therapy (NCT03000634) | University of Arkansas | 2017-04-01 |
| Effect of Hyaluronic-acid on the Healing After Free Gingival Graft (NCT03871218) | Gazi University | 2017-04-01 |
| Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract (NCT03051373) | Chinese PLA General Hospital | 2017-04-01 |
| Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial (NCT03104335) | Peking University People's Hospital | 2017-04-01 |
| Irinotecan for Advanced and Metastatic Breast Cancer (NCT03562390) | Liaoning Cancer Hospital & Institute | 2017-04-01 |
| A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD (NCT03104010) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2017-04-01 |
| Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement (NCT02828358) | National Cancer Institute (NCI) | 2017-04-01 |
| Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis. (NCT03061591) | Tel-Aviv Sourasky Medical Center | 2017-04-01 |
| Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients (NCT03484741) | Van Hanh General Hospital | 2017-04-01 |
| EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide (NCT03341494) | Fujian Cancer Hospital | 2017-04-01 |
| A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART) (NCT03130712) | Shanghai GeneChem Co., Ltd. | 2017-04-01 |
| Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia (NCT02809092) | Hospital de Clinicas de Porto Alegre | 2017-04-01 |
| Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial (NCT03050424) | Royal Brompton & Harefield NHS Foundation Trust | 2017-04-01 |
| The Efficacy of a VR Enhanced Video Exposure Therapy for Dental Phobia (NCT03098134) | Ruhr University of Bochum | 2017-04-01 |
| Endostar First-line Treatment of Advanced NSCLC (NCT03123445) | China Medical University, China | 2017-04-01 |
| Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer (NCT03263741) | Affiliated Hospital of Qinghai University | 2017-04-01 |
| StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies (NCT02765997) | Masonic Cancer Center, University of Minnesota | 2017-04-01 |